Member Info for CHELSEA7

Yeah Moonparty, perhaps, just wanted to put a few thoughts out there at the end of an interesting week.

Enough deep theories for one week for me, I still intend to hold for as long as I can and still 50p with my 180k will make me a very happy young man. As has been the case for 3 weeks now I am still over the moon with my all clear after 10 years, I know I have a compromised lifespan,, but £180k will give me £360 a week more over ten years and I think thatis a realistic target.

Onwards, forwards to next week, sentiment here can change on a sixpence and many thanks to so many for making this an interesting BB to read, we certainly have the posters to learn loads from and I thank you for your posts.

Have a good weekend guys, heres to next week

And there was a delayed 258k sell at 12.3733 from 11.45

Whilst we await to see an accelleration in patients recruitment and dosing it is worth noting we are digging further into funds budgeted for trials, along with a falling value attached to Covidity.

On a positive note our strategy to enrol 125 patients reassures me we have considered our next round of funding whenever needed. I am fully expecting Redmile and Vulpes to take responsibility for that whilst Lindy is left to concentrate on trials and for the moment relieves any pressure in appointing a new CEO when we have a clear strategy going forward. AIMHO

Spiros, quite frankly I do pop up here every year or so, and those who have listened and questioned the nonsense posted here by the rampers have saved themselves fortunes.

PM, it must be years too since I have seen a post here discussing the science behind VALs platforms. Till the next dilution eh!!!

Do not put words into my mouth.

After all these years there is still no institutional investment here, whatever you think it is worth is not backed up by anything in the Pharma world.

Speaking just for myself, I do not understand the clique ramping comments when all VAL has to show is finding someone who would like to take the compounds further IF they had the money. I find this share staggerring!!!!!

PM.................it is even funnier how rampers like yourself get abusive, rather than debate at the slightest hint of truth.

Maybe it should be reminded nothing works yet until it is approved in a phase 3 trial, which VAL are a long way off..as is indeed any sign of a genuine deal which is normal for Val to promise and fail to deliver on. Nothing is even in trial, but a PR Company has been employed I guess to take the high volume of calls away from "Suzy" from PIs beginning to realise they have possibly been taken yet again.

PM, you might do well to justify the M/Caps you make up that the share will breach every week.

A fair bit of any frustration I may of had has gone with some very good posts this week, namely from Burble, Konar and Bermuda fully explaining the steps we are taking that are needed before accelerating the trials and number of patients.

As far as the SP is concerned I do feel that a fair percentage of the fall from 28p has been writing down the asset value of Covidity. That alone has the ability to correct itself massively dependent on new strains of Covid this winter and good data from us.

PM,.......................................................................SOUTHERN INVESTOR is right.

You say..............@Scousegerry that to me indicates news is on the way and they want to maximise the impact to make up for what happened. We are already significantly undervalued which again suggests we will get another mega rise August/Sept this year.

On what basis do you churn out this nonsense week after week?

Morning All, thanks for the posts guys specifically your logic behind timelines.

We have been told that safety and immunogenicity data will still be available this H22022 which could well coincide with the AGM, some 8-12 weeks away.

Dracula...................."""..Sorry but when I hear efficacy data In '23. Covidity Phase 1 Study completion date Dec '22 (Estimated). Everything sounds like years to go yet. AIMO."""

It doesn"t sound "years" away to me fella

Oh the bells, the bells.....................

Morning Cleanerworld, you are the third dyslexic poster who uses this board pretty regularly and I enjoy reading your posts and the sheer amount of research you do in doing so.

Speaking for myself, it is clear what a milestone this news is, but I thi what we are seeing is that data will be the driver here not just confirmaton that the trials are finally underway. For me it is reassuring news but is it enough to attract new PIs? Of that I am less sure. We have stated further news will be announced this half, this year.

I was only aware of the RNS later in the evening but noticed the SP was driven up to 13.75/14 in no time, only to attract a few sellers and seemingly no new PIs. As a LTH I feel more comfortable with the news and it surprises me a few chose to sell as there is plenty of news that could be due in the short term.

Morning All/Rigga, yes the days of even speculative rises for us seem to have passed by.

I was hoping someone might comment on my 17.09 yesterday "Is Covidity even priced in now"?

Burble in asking about Modernas approved COVID vaccine I was leading up to that. I have felt it for some time and it would explain to me why we seem to be treading water even on good news.

With winter fast approaching are the scientists even sure of more deadly strains attacking us?? Look forward to hearing your thoughts guys.

Simply amazed we have fallen back to 12.60/13 after that RNS.

Is Covidity even priced in now?

I get your point WTP but when we consider our strategy for the trial is 125 patients in 20 sites it is easy to deduce we have a long way to go, hence no major uplift

For holders, and speaking for me only I found the RNS Re-Assuring

Thanks Burble, seems with good results we would need a Big Pharma to achieve those inroads into the powers that be and utilise the marketing and manufacture their resources allow. Given the EU is just 13% of the worlds population I wonder if Covidity could be priced accordingly for South America, Africa, Third World countries and emerging nations?

Yeah it did, some really good posts again yesterday.

(Don"t mention Harry Kane, lol)

Burble, I wish I could, but finances will not allow. I am just grateful that when I had to retire 11 years back(20 years too early!!) I very slowly built up a holding of 250k. Scancell remains my last chance to make a life altering sum. I"m down to 180k now, but just for me if we get to 50p that will make a huge difference to my budget and I have always just had that feeling it could happen here.

That is why I found yesterdays RNS exciting as after so long we really are leaving the station and I look forward to the months/years ahead eagerly.

Burble, what are your thoughts regarding the Aproval of Modernas Covid vaccine i relaton to what we are trying to achieve with Covidity??

Morning All/Burble,

I was surprised to see that late RNS yesterday evening and both excited and reassured at the contents therein. I was actually surprised that the SP fell from 13.50/14 to the close but again the volume is so small it pales into significance. Will be interesting to see the trading today and hoping for a decent rise. Have a good day all.

Chester and Konar, good points and the more I read the Rns the more I like it.

We had a good conversation about what might or not be happening at the moment and where the emphasis lies. Ivy raised some pertinent points which I countered by we just do not know what is happening till we get news and I do think many of Ivys concerns have been dealt with today.

For all the quality posts here nobody had a clue of the funding that Redmile and Vulpes were about to announce and I guess that applies to much of what we heard today in the RNS. IF anything we are well ahead of the game I envisaged by todays RNS.

Goes without saying I wish us all the best in the road ahead

Very good point bob.

I know I originally invested here purely as a financial decision. A good reminder to us that the most important people here are the patients all with very poor prognosis. G_d bless them.

Interesting part for me.........

"""Modi-1 is the first candidate of Scancell's Moditope® platform. This open label study will recruit up to 125 patients in up to 20 clinical trial sites across the UK."""

Wonder who is being lined up for our next investment?